Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Pharmacol Biochem Behav. 2012 Nov;103(1):6–17. doi: 10.1016/j.pbb.2012.07.006

Table 2.

Summary of Gene Expression Findings

Gene Brain Region Basal bHR/bLR differences Impact of neonatal FGF2

TH VTA decreased in bLR vs bHR decreased
DAT VTA - -
D2 VTA - -
FGF2 VTA decreased in bLR vs bHR -
FGFR1 VTA - -

TH SN - -
DAT SN - -
D2 SN - -
FGF2 SN decreased in bLR vs bHR -
FGFR1 SN - -

D1 AcbC decreased in bLR vs bHR increased in bLR ONLY
D2 AcbC increased in bLR vs bHR -
FGF2 AcbC decreased in bLR vs bHR increased in bLR ONLY
FGFR1 AcbC - -

D1 AcbSh decreased in bLR vs bHR decreased in bHR ONLY
D2 AcbSh - -
FGF2 AcbSh - -
FGFR1 AcbSh - -

D1 Cpu - decreased in bHR ONLY
D2 Cpu increased in bLR vs bHR -
FGF2 Cpu decreased in bLR vs bHR -
FGFR1 Cpu - -

Abbreviations: tyrosine hydroxylase (TH); dopamine transporter (DAT); dopamine receptor 2 (D2); Fibroblast Growth Factor 2 (FGF2); Fibroblast Growth Factor Receptor 1 (FGFR1); ventral tegmental area (VTA); substantia nigra (SN); nucleus accumbens core (AcbC); nucleus accumbens shell (AcbSh); caudate putament (Cpu)